J. Hodgetts

发表

Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma.

M. Ranson, A. Arance, P. Lorigan, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized P hase I I S tudy o f T emozolomide G iven E very 8 Hours o r D aily W ith E ither I nterferon A lfa-2b o r T halidomide in M etastatic M alignant M elanoma

M. Ranson, A. Arance, P. Lorigan, 2003 .

Identical chemotherapy schedules given on and off trial protocol in small cell lung cancer response and survival results

A. Arance, N. Thatcher, L. Ashcroft, 2002, British Journal of Cancer.

Use of hematopoietic progenitors in whole blood to support dose-dense chemotherapy: a randomized phase II trial in small-cell lung cancer patients.

P. Woll, N. Thatcher, R. Pettengell, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer.

P. Woll, N. Thatcher, V. Cour-Chabernaud, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomised phase II study of standard versus dose-intensive ICE chemotherapy with reinfusion of haemopoietic progenitors in whole blood in small cell lung cancer (SCLC).

P. Woll, N. Thatcher, S. Lee, 1996 .

Prevalence and correlates of unmet supportive care needs in patients with resected invasive cutaneous melanoma.

A. Molassiotis, P. Lorigan, A. Green, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma

P. Lorigan, C. Dive, G. Clack, 2014, Melanoma research.

Vemurafenib-induced nonautoimmune haemolytic anaemia.

M. Dennis, P. Lorigan, J. Hodgetts, 2014, Melanoma research.

Clinical and quality of life outcomes in the first United Kingdom randomized trial of endobronchial brachytherapy (intraluminal radiotherapy) vs. external beam radiotherapy in the palliative treatment of inoperable non-small cell lung cancer.

P. Barber, P. Hopwood, R. Swindell, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Understanding and Managing Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Patients With Advanced Melanoma

R. Gordon, M. Burke, Smita Ranjan, 2017, Journal of the advanced practitioner in oncology.

European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanoma.

P. Ascierto, M. Mandalà, T. Mussack, 2023, The British journal of surgery.

P-574 Randomised phase 3 trial of autologous blood progenitor cell and filgrastim supported dose dense ICE chemotherapy versus standard ICE in good prognosis small cell lung cancer (SCLC) — a different toxicity profile

P. Lorigan, P. Woll, N. Thatcher, 2003 .